Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Low frequency of slow debrisoquine hydroxylation in a native Chinese population.

Literature DB >> 2889047

Low frequency of slow debrisoquine hydroxylation in a native Chinese population.

Y C Lou, L Ying, L Bertilsson, F Sjöqvist.

Abstract

Entities: Chemical

Mesh：

Substances：
Isoquinolines
Debrisoquin

Year: 1987 PMID： 2889047 DOI： 10.1016/s0140-6736(87)91034-8

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

1. Genetic polymorphism of CYP2D6 in a keralite (South India) population.

Authors: B K Abraham; C Adithan; C H Shashindran; S Vasu; N A Alekutty
Journal: Br J Clin Pharmacol Date: 2000-03 Impact factor: 4.335

2. Effect of CYP2D6*10 on pharmacokinetic variability of routinely administered metoprolol in middle-aged and elderly Japanese patients.

Authors: Masato Taguchi; Takashi Nozawa; Tomoki Kameyama; Hiroshi Inoue; Chihiro Takesono; Akiko Mizukami; Yukiya Hashimoto
Journal: Eur J Clin Pharmacol Date: 2003-08-12 Impact factor: 2.953

3. Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population.

Authors: B S Doshi; R D Kulkarni; B L Chauhan; G R Wilkinson
Journal: Br J Clin Pharmacol Date: 1990-11 Impact factor: 4.335

4. Uses and misuses of definitions of genetic polymorphism. A perspective from population pharmacogenetics.

Authors: T D Arias; L F Jorge; R Barrantes
Journal: Br J Clin Pharmacol Date: 1991-01 Impact factor: 4.335

5. Polymorphism of debrisoquine oxidation in New Zealand Caucasians.

Authors: S Wanwimolruk; J R Denton; D G Ferry; M Beasley; J R Broughton
Journal: Eur J Clin Pharmacol Date: 1992 Impact factor: 2.953

6. Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.

Authors: I Johansson; Q Y Yue; M L Dahl; M Heim; J Säwe; L Bertilsson; U A Meyer; F Sjöqvist; M Ingelman-Sundberg
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

Low frequency of slow debrisoquine hydroxylation in a native Chinese population.

1. Genetic polymorphism of CYP2D6 in a keralite (South India) population.

2. Effect of CYP2D6*10 on pharmacokinetic variability of routinely administered metoprolol in middle-aged and elderly Japanese patients.

3. Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population.

4. Uses and misuses of definitions of genetic polymorphism. A perspective from population pharmacogenetics.

5. Polymorphism of debrisoquine oxidation in New Zealand Caucasians.

6. Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.

Review 7. Ethnic differences in drug disposition and responsiveness.

8. Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese.

9. Clinical significance of the sparteine/debrisoquine oxidation polymorphism.

10. Metoprolol oxidation in a Japanese population: evidence for only one poor metaboliser among 262 subjects.